|
Ki-1+ Anaplastic Large Cell Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
<i>DUSP22-</i>rearranged ALCLs also overexpressed immunogenic cancer-testis antigen (CTA) genes and showed marked DNA hypomethylation by reduced representation bisulfate sequencing and DNA methylation arrays.
|
30093402 |
2018 |
|
Hypertensive disease
|
0.010 |
Biomarker
|
group |
BEFREE |
(1) Patients with HIE, who had a history of stroke and hypertension, showed more severe stenosis on CTA and more perfusion abnormalities compared to non-HIE patients (p < 0.05).
|
28454490 |
2017 |
|
Hypoxic-Ischemic Encephalopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
(1) Patients with HIE, who had a history of stroke and hypertension, showed more severe stenosis on CTA and more perfusion abnormalities compared to non-HIE patients (p < 0.05).
|
28454490 |
2017 |
|
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
4D-CTA with a wide scan range and precise injection timing methods facilitated an anatomical approach to tumor-related vascular structures, providing detailed vascular information.
|
28288528 |
2017 |
|
Cerebral Aneurysm
|
0.010 |
Biomarker
|
disease |
BEFREE |
4D-CTA may be considered as a follow-up imaging tool for hemodynamic assessment of cerebral aneurysms.
|
31772042 |
2019 |
|
Arteriosclerotic cardiovascular disease, NOS
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
6439 low-to-intermediate ASCVD-risk patients (57.9 ± 11.1 years; 44.4% females) who underwent CTA and CCS were enrolled.
|
31570324 |
2019 |
|
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
73 asymptomatic individuals at increased risk of CAD due to peripheral vascular disease (18 women, mean age 63.5 ± 8.2 years) underwent coronary computed tomography angiography (coronary CTA) using first generation dual-source CT. Curvature and tortuosity of the coronary arteries were quantified using semi-automatically generated centerlines.
|
29486988 |
2018 |
|
Peripheral Vascular Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
73 asymptomatic individuals at increased risk of CAD due to peripheral vascular disease (18 women, mean age 63.5 ± 8.2 years) underwent coronary computed tomography angiography (coronary CTA) using first generation dual-source CT. Curvature and tortuosity of the coronary arteries were quantified using semi-automatically generated centerlines.
|
29486988 |
2018 |
|
SPINOCEREBELLAR ATAXIA 8
|
0.020 |
Biomarker
|
disease |
BEFREE |
Spinocerebellar ataxia type 8 (SCA8) is caused by the expansion of CTA/CTG triplet repeats on 13q21.Cases can be familial or sporadic.
|
15823478 |
2005 |
|
Carotid artery occlusion
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Carotid artery occlusion was defined as 100% cross-sectional occlusion of the vessel lumen as documented on CTA or MRA and confirmed by digital subtraction angiography.RESULTSFour types (A-D) of radiographic COICA were identified.
|
29775153 |
2018 |
|
Congenital anomaly of coronary artery
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Coronary artery anomalies are relatively rare (approximately 1% on CTA).
|
30158328 |
2018 |
|
Dysarthria
|
0.010 |
Biomarker
|
disease |
BEFREE |
Dysarthria and right-sided limb ataxia were newly developed before DWI (after p-CTA).
|
30593199 |
2018 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
CTA in patients with acute ischemic stroke shows large individual variations of occlusion sites and degrees.
|
28302611 |
2017 |
|
Atrial Septal Defects
|
0.010 |
Biomarker
|
group |
BEFREE |
A 3D model printed from the CTA was used to simulate device deployment, demonstrating successful exclusion of the sinus venosus ASD with return of the RUPV to the left atrium (LA).
|
29897667 |
2018 |
|
Autism Spectrum Disorders
|
0.010 |
Biomarker
|
disease |
BEFREE |
A 3D model printed from the CTA was used to simulate device deployment, demonstrating successful exclusion of the sinus venosus ASD with return of the RUPV to the left atrium (LA).
|
29897667 |
2018 |
|
ATRIAL SEPTAL DEFECT 1
|
0.010 |
Biomarker
|
disease |
BEFREE |
A 3D model printed from the CTA was used to simulate device deployment, demonstrating successful exclusion of the sinus venosus ASD with return of the RUPV to the left atrium (LA).
|
29897667 |
2018 |
|
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
A CTA # 2E-reactive human single-chain (sc)Fv was selected by panning the larger library on decreasing concentrations of biotinylated tumor-associated antigen in solution.
|
9853954 |
1998 |
|
Aortitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
A CT without contrast showing infiltration around the aorta should, in some context, be promptly followed by Aortic CTA to search for acute aortitis among other less urgent differentials.
|
29903668 |
2018 |
|
Acute Chest Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
A retrospective observational case-control study was performed of 246 ED patients referred to coronary CTA with suspicion of ACS (56.5% male; mean age 53.3 ± 11.6 years) between October 2013 and August 2015.123 consecutive patients were scanned on 3rd generation DSCT, and a cohort of 123 patients matched by age, BMI and heart rate were identified who had undergone 2nd generation DSCT imaging utilizing the same standard clinical protocol.
|
28506470 |
2018 |
|
Cerebrovascular accident
|
0.080 |
Biomarker
|
group |
BEFREE |
A retrospective review of neck CTA studies in young patients with cryptogenic stroke over the past 6 years (<i>n</i> = 33) was performed to determine the prevalence of carotid webs compared with a control group of patients who received neck CTA studies for reasons other than ischemic stroke (<i>n</i> = 63).
|
28495950 |
2017 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
A series of consecutive patients with a clinical diagnosis of brain death underwent CTA (case group), while the control group comprised patients with acute ischemic stroke in the same period.
|
31196858 |
2019 |
|
Chronic Kidney Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
A theoretical insight to understand the molecular mechanism of dual target ligand CTA-018 in the chronic kidney disease pathogenesis.
|
30286109 |
2018 |
|
Aortic Aneurysm, Abdominal
|
0.020 |
Biomarker
|
disease |
BEFREE |
A total of 168 patients undergoing successful EVAR for abdominal aortic aneurysms with CTA follow-up of at least 1 year were included.
|
31250171 |
2019 |
|
Dural Arteriovenous Fistula
|
0.020 |
Biomarker
|
disease |
BEFREE |
A transverse-sigmoid dAVF was detected on magnetic resonance angiography (MRA) and three-dimensional-CT angiography (3D-CTA), with no cortical venous reflex.
|
30227805 |
2019 |
|
Chronic Lymphocytic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Abbreviations: APC/C: Anaphase-Promoting Complex/Cyclosome; BAD: BCL2-Associated agonist of cell Death; BAK1: BCL2 Antagonist Kinase1; BAX: BCL2-Associated X; BCL2: B-cell Chronic Lymphocytic Leukaemia (CLL)/Lymphoma 2; BH: BCL2 Homology Domain; BID: BH3-Interacting domain Death agonist; BIM: BCL2-Interacting Mediator of cell death; BUB: Budding Uninhibited by Benzimidazoles; CDC: Cell Division Cycle; CDH1: Cadherin-1; CDK1: Cyclin-Dependent Kinase 1; CEP55: Centrosomal Protein (55 KDa): CIN: Chromosomal Instability; CTA: Cancer Testis Antigen; EGR1: Early Growth Response protein 1; ERK: Extracellular Signal-Regulated Kinase; ESCRT: Endosomal Sorting Complexes Required for Transport; GIN: Genomic Instability; MAD2: Mitotic Arrest Deficient 2; MCL1: Myeloid Cell Leukemia sequence 1; MPS1: Monopolar Spindle 1 Kinase; MYT1: MYelin Transcription factor 1; PLK1: Polo Like Kinase 1; PUMA: p53-Upregulated Mediator of Apoptosis; SAC: Spindle Assembly Checkpoint; TAA: Tumor-Associated Antigen.
|
30601084 |
2019 |